We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.97B
AUM Growth
+$340M
Cap. Flow
+$192M
Cap. Flow %
3.86%
Top 10 Hldgs %
23.72%
Holding
1,286
New
328
Increased
312
Reduced
279
Closed
346

Sector Composition

Rank Sector Weight
1 Real Estate 12.54%
2 Energy 9.89%
3 Financials 8.72%
4 Industrials 6.89%
5 Consumer Discretionary 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANR
876
DELISTED
Alpha Natural Resources Inc
ANR
$239K ﹤0.01%
+56,120
New +$301K
INFI
877
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$238K ﹤0.01%
+20,000
New +$268K
CFN
878
DELISTED
CAREFUSION CORPORATION
CFN
$237K ﹤0.01%
5,890
+310
+6% +$12.5K
GEVA
879
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$236K ﹤0.01%
+2,840
New +$263K
SIRO
880
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$234K ﹤0.01%
3,140
-150
-5% -$10.7K
LGND icon
881
Ligand Pharmaceuticals
LGND
$6.02B
$231K ﹤0.01%
5,514
-6,140
-53% -$256K
INSM icon
882
Insmed
INSM
$23.2B
$230K ﹤0.01%
12,100
+970
+9% +$18.4K
EBS icon
883
Emergent Biosolutions
EBS
$375M
$229K ﹤0.01%
+9,050
New +$229K
MDAS
884
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
$228K ﹤0.01%
9,220
-1,180
-11% -$26.6K
GMED icon
885
Globus Medical
GMED
$10.4B
$227K ﹤0.01%
8,520
-2,990
-26% -$71K
CPRX
886
DELISTED
Catalyst Pharmaceutical
CPRX
$226K ﹤0.01%
+100,000
New +$209K
SGMO
887
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$226K ﹤0.01%
12,500
-570
-4% -$11K
STE icon
888
Steris
STE
$20.9B
$226K ﹤0.01%
4,730
-120
-2% -$5.62K
INCY icon
889
Incyte
INCY
$23.5B
$224K ﹤0.01%
+4,180
New +$259K
HALO icon
890
Halozyme
HALO
$9.72B
$222K ﹤0.01%
17,500
+5,020
+40% +$74.5K
NUVA
891
DELISTED
NuVasive, Inc.
NUVA
$222K ﹤0.01%
5,770
-1,080
-16% -$39.7K
MYGN icon
892
Myriad Genetics
MYGN
$530M
$221K ﹤0.01%
6,450
-9,560
-60% -$296K
BALT
893
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$220K ﹤0.01%
+34,880
New +$221K
RPTP
894
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$220K ﹤0.01%
22,000
+8,210
+60% +$119K
CRL icon
895
Charles River Laboratories
CRL
$10.9B
$218K ﹤0.01%
3,610
-630
-15% -$36.7K
IMGN
896
DELISTED
Immunogen Inc
IMGN
$217K ﹤0.01%
14,550
+2,630
+22% +$41.5K
NTUS
897
DELISTED
Natus Medical Inc
NTUS
$217K ﹤0.01%
+8,430
New +$212K
MASI
898
DELISTED
Masimo
MASI
$215K ﹤0.01%
7,870
+120
+2% +$3.42K
SRPT icon
899
Sarepta Therapeutics
SRPT
$1.66B
$215K ﹤0.01%
+8,950
New +$228K
SGEN
900
DELISTED
Seagen Inc. Common Stock
SGEN
$215K ﹤0.01%
+4,720
New +$226K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Weiss Multi-Strategy Advisers held 1,286 positions worth $4.97B, up 7.3% from $4.63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Weiss Multi-Strategy Advisers deployed $192M of net new capital in Q1 2014, opening 328 new positions and adding to 312 existing holdings. Its largest new stake was Hudson Pacific Properties: 335,714 shares worth $54.2M.

By sector, the portfolio is most concentrated in Real Estate at 13% of assets, down from 13% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Liberty Property Trust, an estimated $43.8M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2014 buy was Hudson Pacific Properties: 335,714 shares worth $54.2M.
  • Weiss Multi-Strategy Advisers added most to LXP Industrial Trust in Q1 2014, an estimated $24.3M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2014 reduction was Liberty Property Trust, cutting an estimated $43.8M.
  • Weiss Multi-Strategy Advisers fully exited RETAIL PROPERTIES OF AMERICA, INC. in Q1 2014, selling an estimated $36.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 24% of its $4.97B portfolio in Q1 2014.
  • Weiss Multi-Strategy Advisers opened 328 new positions and closed 346 in Q1 2014.
  • Weiss Multi-Strategy Advisers's portfolio value rose 7.3% quarter-over-quarter to $4.97B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.